Results 131 to 140 of about 27,057 (223)

A breakthrough invasive <i>Aspergillus granulosus</i> infection following azole antifungal therapy in a patient with primary myelofibrosis: case report. [PDF]

Med Mycol Case Rep
Jaroensawang W, Chongtrakool P, Chayakulkeeree M, Jitmuang A.   +3 more
europepmc   +1 more source

Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report. [PDF]

Front Oncol
Qiu CE, Lei L, Jiang G, Huang X, Li Y.
europepmc   +1 more source

Primary myelofibrosis

, 2021
openaire   +1 more source

Primary myelofibrosis with increased haemoglobin concentration at presentation. [PDF]

Br J Haematol
Barosi G, Campanelli R, Catarsi P, Abbà C, Carolei A, Massa M, De Silvestri A, Gale RP, Rosti V.   +8 more
europepmc   +1 more source

Machine learning identifies inflammation-related diagnostic biomarkers for primary myelofibrosis with clinical validation. [PDF]

Sci Rep
Li R, Han Q, Zeng T, Wen B, Zheng Z, Bao X, Huang J.   +6 more
europepmc   +1 more source

Is it primary myelofibrosis or chronic megakaryocytic leukemia? [PDF]

Haematologica, 2022
Lichtman MA.
europepmc   +1 more source

Sweet's syndrome with Koebner phenomenon triggered by G-CSF as a preleukemic manifestation in a patient with primary myelofibrosis: a case report. [PDF]

Front Med (Lausanne)
Zhang Z, Zhou D, Liu Y, Meng L, Ji B.
europepmc   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context [PDF]

, 2016
Harrison, Claire, McMullin, Mary Frances
core   +1 more source

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [PDF]

, 2014
DiPersio, John F, et al,
core   +1 more source